|
Suppliers for CAS
665-66-7
|
Properties | | CAS |
665-66-7 | | Formula |
C10H17N.HCl | | EINECS |
211-560-2 |
|
|
25 Registered suppliers
Aecochem Corp.
P.R.China
Dayang Chem (Hangzhou) Co.,Ltd.
P.R.China
Sancai Industry Co.,Ltd.
P.R.China
Hangzhou Keying Chem Co., Ltd.
P.R.China
H&Z Industry Co.,Ltd
P.R.China
Xingrui Industry Co., Limited
P.R.China
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd)
P.R.China
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C10H17N.HCl Molecular Weight: 187.71
More details are to be found here
Sigma-Aldrich International GmbH
Switzerland
Molecular Formula: C10H17N.HCl Molecular Weight: 187.71
More details are to be found here
Hangzhou Verychem Science & Technology Co., Ltd.
P.R.China
Molecular Formula: C10H17N.HCl Molecular Weight: 187.71
More details are to be found here
Zouping Mingxing Chemical Co., Ltd.
P.R.China
Molecular Formula: C10H17N.HCl Molecular Weight: 187.71
More details are to be found here
AXO Industry SA
Belgium
Molecular Formula: C10H17N.HCl Molecular Weight: 187.71
More details are to be found here
Hangzhou Zhongqi Chem Co., Ltd
P.R.China
Molecular Formula: C10H17N.HCl Molecular Weight: 187.71
More details are to be found here
Finetech Industry Limited
P.R.China
More details are to be found here
Hangzhou Lingrui Chemical Co., Ltd.
P.R.China
More details are to be found here
Skyrun Industrial Co., Ltd.
P.R.China
More details are to be found here
Shandong SanYoung Industry Co., Ltd
P.R.China
Carbone Scientific Co., Ltd.
U.K.
BLD Pharmatech Ltd
P.R.China
Smile code: NC12CC3CC(C2)CC(C3)C1.[H]Cl MDL Number: MFCD00074723 Purity : 98% Available in stock: 34551.003 g
More details are to be found here
Xiamen Equation Chemical Co.,Ltd
P.R.China
Smile code: NC12CC3CC(C2)CC(C3)C1.[H]Cl MDL Number: MFCD00074723 Purity : 98% Available in stock: 34551.003 g
More details are to be found here
AK Scientific, Inc.
USA
Smile code: NC12CC3CC(C2)CC(C3)C1.[H]Cl MDL Number: MFCD00074723 Purity : 98% Available in stock: 34551.003 g
More details are to be found here
BuGuCh & Partners
Germany
Smile code: NC12CC3CC(C2)CC(C3)C1.[H]Cl MDL Number: MFCD00074723 Purity : 98% Available in stock: 34551.003 g
More details are to be found here
Smile code: NC12CC3CC(C2)CC(C3)C1.[H]Cl MDL Number: MFCD00074723 Purity : 98% Available in stock: 34551.003 g
More details are to be found here
The density is 1.067g/cm3, white crystalline powder. It is soluble in water, methanol and ethanol, slightly soluble in acetic acid and chloroform, and almost insoluble in benzene, ether and petroleum ether.
It can effectively prevent and treat various influenza A virus infections in clinical practice. The protection rate of this product can reach 50%~79% when it is used as a preventive drug during the epidemic period of influenza. For those who have already been infected, if the drug is administered within 48 hours, it can effectively treat respiratory symptoms caused by influenza A virus.
After entering the brain tissue, it can promote the release of dopamine, or delay the metabolism of dopamine to play the role of anti paralysis. It has obvious curative effect on tremor paralysis, and has good effect on relieving tremor and stiffness. Rapid onset The effect is obvious 48 hours after administration, and it has a good antipyretic effect on many kinds of inflammation, sepsis, viral pneumonia, etc. To prevent and treat influenza A virus in patients with primary tremor paralysis, cerebral arteriosclerosis and tremor paralysis syndrome after encephalitis.
World. Chem. Co., Ltd.
P.R.China
The density is 1.067g/cm3, white crystalline powder. It is soluble in water, methanol and ethanol, slightly soluble in acetic acid and chloroform, and almost insoluble in benzene, ether and petroleum ether.
It can effectively prevent and treat various influenza A virus infections in clinical practice. The protection rate of this product can reach 50%~79% when it is used as a preventive drug during the epidemic period of influenza. For those who have already been infected, if the drug is administered within 48 hours, it can effectively treat respiratory symptoms caused by influenza A virus.
After entering the brain tissue, it can promote the release of dopamine, or delay the metabolism of dopamine to play the role of anti paralysis. It has obvious curative effect on tremor paralysis, and has good effect on relieving tremor and stiffness. Rapid onset The effect is obvious 48 hours after administration, and it has a good antipyretic effect on many kinds of inflammation, sepsis, viral pneumonia, etc. To prevent and treat influenza A virus in patients with primary tremor paralysis, cerebral arteriosclerosis and tremor paralysis syndrome after encephalitis.
Merck Schuchardt OHG
Germany
The density is 1.067g/cm3, white crystalline powder. It is soluble in water, methanol and ethanol, slightly soluble in acetic acid and chloroform, and almost insoluble in benzene, ether and petroleum ether.
It can effectively prevent and treat various influenza A virus infections in clinical practice. The protection rate of this product can reach 50%~79% when it is used as a preventive drug during the epidemic period of influenza. For those who have already been infected, if the drug is administered within 48 hours, it can effectively treat respiratory symptoms caused by influenza A virus.
After entering the brain tissue, it can promote the release of dopamine, or delay the metabolism of dopamine to play the role of anti paralysis. It has obvious curative effect on tremor paralysis, and has good effect on relieving tremor and stiffness. Rapid onset The effect is obvious 48 hours after administration, and it has a good antipyretic effect on many kinds of inflammation, sepsis, viral pneumonia, etc. To prevent and treat influenza A virus in patients with primary tremor paralysis, cerebral arteriosclerosis and tremor paralysis syndrome after encephalitis.
Santa Cruz Biotechnology, Inc.
USA
The density is 1.067g/cm3, white crystalline powder. It is soluble in water, methanol and ethanol, slightly soluble in acetic acid and chloroform, and almost insoluble in benzene, ether and petroleum ether.
It can effectively prevent and treat various influenza A virus infections in clinical practice. The protection rate of this product can reach 50%~79% when it is used as a preventive drug during the epidemic period of influenza. For those who have already been infected, if the drug is administered within 48 hours, it can effectively treat respiratory symptoms caused by influenza A virus.
After entering the brain tissue, it can promote the release of dopamine, or delay the metabolism of dopamine to play the role of anti paralysis. It has obvious curative effect on tremor paralysis, and has good effect on relieving tremor and stiffness. Rapid onset The effect is obvious 48 hours after administration, and it has a good antipyretic effect on many kinds of inflammation, sepsis, viral pneumonia, etc. To prevent and treat influenza A virus in patients with primary tremor paralysis, cerebral arteriosclerosis and tremor paralysis syndrome after encephalitis.
The density is 1.067g/cm3, white crystalline powder. It is soluble in water, methanol and ethanol, slightly soluble in acetic acid and chloroform, and almost insoluble in benzene, ether and petroleum ether.
It can effectively prevent and treat various influenza A virus infections in clinical practice. The protection rate of this product can reach 50%~79% when it is used as a preventive drug during the epidemic period of influenza. For those who have already been infected, if the drug is administered within 48 hours, it can effectively treat respiratory symptoms caused by influenza A virus.
After entering the brain tissue, it can promote the release of dopamine, or delay the metabolism of dopamine to play the role of anti paralysis. It has obvious curative effect on tremor paralysis, and has good effect on relieving tremor and stiffness. Rapid onset The effect is obvious 48 hours after administration, and it has a good antipyretic effect on many kinds of inflammation, sepsis, viral pneumonia, etc. To prevent and treat influenza A virus in patients with primary tremor paralysis, cerebral arteriosclerosis and tremor paralysis syndrome after encephalitis.
|
_Co_Ltd_1_575.jpg){kind=logo}
details
details
details